L-Poladdict

Levomethadone, the active ingredient in L-Poladdict, is an opioid presented as an oral formulation for oral use. It is indicated for the treatment of opioid dependence and helps to reduce withdrawal symptoms in affected individuals.

GNH USA supplies L-Poladdict as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levomethadone is used in opioid dependence management and related therapeutic pathways.

- Opioid dependence: supports maintenance therapy to help patients remain abstinent from illicit opioids. - Opioid withdrawal: alleviates acute withdrawal symptoms during detoxification. - Opioid substitution therapy: provides stable mu‑opioid receptor activation as an alternative to other opioids.

Levomethadone may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: feeling of sickness or urge to vomit. - Constipation: reduced bowel movements and hard stools. - Dizziness: light‑headedness or unsteady sensation. - Sedation: increased sleepiness or drowsiness. - Sweating: excessive perspiration unrelated to temperature. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - QT interval prolongation: cardiac electrical disturbance that may lead to arrhythmia. - Severe hypotension: marked drop in blood pressure causing faintness. - Cardiac arrhythmia: irregular heart rhythm requiring urgent care. - Seizures: convulsive episodes in susceptible individuals. - Allergic reactions: rash, itching, swelling, or anaphylaxis.

When prescribing levomethadone, clinicians should observe several safety measures.

- Assess liver function: evaluate hepatic status before initiating therapy. - Monitor respiratory status: watch for signs of respiratory depression, especially during dose adjustments. - Evaluate cardiac QT interval: perform ECG monitoring in patients at risk for QT prolongation. - Avoid use in severe respiratory depression: contraindicated in patients with compromised breathing. - Use caution in pregnancy: safety category unknown; weigh benefits against potential risks. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Levomethadone can interact with various medications, requiring careful management.

Major Interactions (Avoid): - Central nervous system depressants: concurrent use with benzodiazepines or barbiturates may cause profound sedation. - MAO inhibitors: risk of severe hypotension and serotonin syndrome. - Strong CYP3A4 inhibitors: agents like ketoconazole can increase levomethadone plasma levels. - Other opioids: additive respiratory depression risk.

Moderate Interactions (Monitor Closely): - CYP2B6 inducers: drugs such as rifampin may reduce levomethadone effectiveness. - Alcohol: may enhance sedative effects and respiratory depression. - Certain antidepressants: may alter opioid metabolism or increase QT prolongation risk.